Sabr/Aesi Manager, Drug Safety And Risk Management
Cambridge, Ma, Us
Implemented PV activities in all phases of ICSR processing and regulatory reporting for clinical and post-marketing cases.Led PML adjudication meetings for Biogen's MS franchise products as SME for Medical Evaluation Team and PV Scientists, managing safety signal detection and due-dilligence initiatives to advance the understanding of the safety profile of Biogen's products.Communicated new and important clinical data with senior-level stakeholders across Medical Safety and provided operational support to clinical programs and special projects.Supported Commercial Team’s initiatives to strengthen HCP relationships within Biogen Safety.Provided Medical Information safety data and analysis for the preparation of Scientific publications/ journals, manuscripts, and conference materials.Performed CRO training and oversight of case processing and AESI follow-up activities, tracking internal guidelines and compliance goals for all core responsibilities (incl. triage, assessments, due diligence activities, MedDRA and WHO drug coding, clinical narratives, timely submissions, etc,).Approved Late Case Investigations (LCIs) and Corrective Action Plans (CAPAs).Mentored junior members to industry regulations, guidelines (i.e., ICH, GCP), and Biogen-specific SOPs.Co-developed and updated job-related SOPs.Validated compliance data and managed quality oversight activities that supported monthly compliance metrics for CRO and business partner activities.Managed CRO team meetings; providing job aids, real-time feedback, and quality improvements to on-the-job challenges.Coordinated the clinical data provision and analysis for aggregate reports (PSUR, PADER, Annual Reports). Worked cross-functionally with members of Global Safety to respond to special inquiries from Regulatory and Health Authorities, safety data was validated, and all commitments fulfilled.Provided support and AESI case data expertise during inspection readiness operations and audits.